KR20170135416A - A chinese medicine composition and preparation method thereof - Google Patents
A chinese medicine composition and preparation method thereof Download PDFInfo
- Publication number
- KR20170135416A KR20170135416A KR1020160067301A KR20160067301A KR20170135416A KR 20170135416 A KR20170135416 A KR 20170135416A KR 1020160067301 A KR1020160067301 A KR 1020160067301A KR 20160067301 A KR20160067301 A KR 20160067301A KR 20170135416 A KR20170135416 A KR 20170135416A
- Authority
- KR
- South Korea
- Prior art keywords
- grams
- ginseng
- filtrate
- chinese medicine
- medicine composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 담석 치료용 중국 의약 조성물 및 그 제조 방법에 관한 것이다.The present invention relates to a Chinese medicine composition for treating gallstones and a method for producing the same.
담석 (gallstone)은 담낭 및 간내 담관의 부위에서 주로 발생하는 일반적인 질환이다. 담석은 수술 요법, 쇄석 (gallstone-breaking) 요법, 및 배석 (lithagogue) 요법에 의해 주로 치료되고, 여기서, 상기 수술 요법 및 상기 쇄석 요법은 즉시 효과가 있을 수 있지만, 두 요법 모두는 수술 후 재발의 문제를 전혀 해결하지 못하고 있으며, 그것은 환자에게 고통을 가져 올 수 있다. 비록 중국 전통 의약에 의한 담석의 치료는 오랜 역사를 가지고 있으며, 전통 중국 의약 요법은 점점 더 사람들의 관심을 받고 있지만, 신속한 약리학적 효과를 갖는 중국 의약 조성물은 여전히 존재하지 않는다.Gallstone is a common disease that occurs mainly in gallbladder and intrahepatic bile duct sites. Gallstones are primarily treated by surgical therapy, gallstone-breaking therapy, and lithogogue therapy, where both surgery and the stone therapy can be effective immediately, It has not solved the problem at all, and it can cause pain to the patient. Although the treatment of gallstones by Chinese traditional medicines has a long history and traditional Chinese medicines are getting more and more popular, there is still no Chinese medicinal composition with rapid pharmacological effect.
본 발명은 담석 치료용 중국 의약 조성물을 개시하고, 이것은 담즙 흐름을 촉진시키기 위하여 침체된 간의 기 (Qi: 氣)를 분산시키고, 기 순환을 촉진하여 통증을 완화시키는 효과를 가지며, 간결석 (hepatolith) 및 담석을 치료하는 현저한 치료적 효과를 가지고, 신속한 약리학적 효과를 갖는다. The present invention discloses a Chinese medicinal composition for treating gallstones, which has the effect of dispersing stagnant liver (Qi: Ki) to promote bile flow, facilitating circulation and alleviating pain, and hepatolith ) And gallstones, and has a rapid pharmacological effect.
본 발명은 다음과 같이 실현된다: 이것은 다음을 중량 기준으로 포함한다: 170 내지 175g의 시호 (Radix Bupleuri), 110 내지 120g의 작약 (Radix Paeoniae Rubra), 130 내지 135g의 태자삼 (Radix Pseudostellariae), 50 내지 55g의 지실 (Fructus Aurantii Immaturus), 65 내지 70g의 금은화 (Lonicera japonica), 30 내지 40g의 통초 (Ricepaperplant Pith), 30 내지 40g의 백목이 (Tremella fuciformis), 20 내지 25g의 황기 (Astragalus membranaceus), 65 내지 70g의 당삼 (Codonopsis pilosula), 25 내지 30g의 황금 (Scutellaria baicalensis), 40 내지 45g의 울금 (Radix Curcumae), 65 내지 70g의 해금사 (Lygodium japonicum), 140 내지 150g의 연교 (Fructus Forsythiae), 및 30 내지 40g의 포공영 (dandelion). 그 제조 방법은 다음을 포함한다: 연교, 태자삼 및 작약을 분쇄하고, 그것을 120 메쉬 체로 체질(sieving) 하여 미세 분말을 얻는 단계; 물과 함께 시호를 끓이고, 여과하여 여과액을 얻고, 상기 여과액을 농축시켜 60℃에서 측정 시 1.02 내지 1.03의 상대 밀도를 갖는 농고 (stiff paste)를 얻는 단계; 포공영, 통초, 당삼, 지실, 금은화, 황금, 및 울금을 증기 (steam) 증류하여 휘발성 유 (volatile oil)를 추출하고, β-시클로덱스트린으로 상기 휘발성 유를 포접화 (clathration)하여 포접 화합물 (clathrate compound)을 얻고, 상기 포접 화합물을 건조하고, 그것을 분말로 분쇄하고, 용기 내에 상기 분말을 두는 단계; 및 증기 증류 후에 얻어진 찌꺼기 (dreg), 황기, 백목이, 및 해금사의 혼합물을 물과 함께 1시간씩, 3회 달여서 탕액을 얻고, 상기 탕액을 혼합하고, 여과하여 여과액을 얻고, 상기 여과액을 농축시켜 60℃에서 측정 시 1.25 내지 1.30의 상대 밀도를 갖는 농고를 얻고, 상기 시호 농고 및 연교, 태자삼 및 작약의 미세 분말을 첨가하여, 균일하게 혼합하고, 4% 전분 슬러리를 첨가하고, 균일하게 교반하고, 건조하고, 정립 (size stabilization: 整粒)을 수행하고, 휘발성 유 포접 화합물 미세 분말 및 1% 스테아르산을 첨가하여, 캡슐제, 정제 또는 과립제로 만드는 단계.The present invention is realized as follows: This includes by weight: Radix Bupleuri 170-175 g, Radix Paeoniae Rubra 110-120 g Radix Pseudostellariae 130-135 g, Fructus Aurantii Immaturus, Lonicera japonica, 30 to 40 g Ricepaperplant Pith, 30 to 40 g Tremella fuciformis, 20-25 g of Astragalus membranaceus, ), 65 to 70 g of Codonopsis pilosula, 25 to 30 g of Scutellaria baicalensis, 40 to 45 g of Radix Curcumae, 65 to 70 g of Lygodium japonicum, 140 to 150 g of Fructus Forsythiae ), And 30 to 40 g of dandelion. The preparation method comprises: pulverizing alum, mandarin and peony, and sieving it with a 120-mesh sieve to obtain a fine powder; Boiling the seaweed together with water, filtering to obtain a filtrate, and concentrating the filtrate to obtain a stiff paste having a relative density of 1.02 to 1.03 as measured at 60 ° C; Volatile oil is extracted by steam distillation from a mixture of glacial acetic acid, glacial acetic acid, ginseng, sugar bean ginseng, gilt earthen, golden ginseng and golden ginseng, clathration of the volatile oil with? -Cyclodextrin, compound, drying the inclusion compound, pulverizing it into a powder, and placing the powder in a container; And a mixture of dreg, ylang, kaolin, and sea liquor obtained after steam distillation with water for 1 hour for 3 hours to obtain a bath liquid, mixing the bath liquid and filtering to obtain a filtrate, And concentrated to obtain a concentrate having a relative density of 1.25 to 1.30 as measured at 60 캜, adding the above-mentioned fine granules and the fine powder of the granules, the granules and the granules, uniformly mixing, adding a 4% starch slurry, Uniformly stirring, drying, performing size stabilization, and adding volatile oil-containing compound fine powder and 1% stearic acid to make capsules, tablets or granules.
본 발명의 중국 의약 조성물은 담즙 흐름을 촉진시키기 위하여 침체된 간의 기를 분산시키고, 기 순환을 촉진하여 통증을 완화시키는 효과를 가지며; 기 정체, 간내 담관 결석, 및 담석에 의한 늑골통 (costalgia)의 치료를 위해 사용될 수 있으며; 캡슐제, 정제 또는 과립제로 만들어질 수 있고; 합리적인 처방, 편리하고 안전한 복용, 신속한 약리학적 효과, 단기간의 치료 과정, 우수한 배석 (stone discharging) 효과, 환자의 고통이 없음, 및 중대한 독성 및 부작용이 없는 이점들을 갖는다. The Chinese medicine composition of the present invention has an effect of dispersing stagnant liver groups to promote bile flow and promoting circulation to alleviate pain; Can be used for the treatment of gastrointestinal stones, intrahepatic bile duct stones, and costalgia due to gallstones; Capsules, tablets or granules; Have advantages of reasonable prescription, convenient and safe dosing, rapid pharmacological effect, short term treatment process, excellent stone discharging effect, no patient suffering, and no significant toxicity and side effects.
본 발명은 하기 실시예에 의하여 더욱 상세하게 설명되어진다.The present invention will be explained in more detail by the following examples.
실시예 1Example 1
원료들을 다음과 같이 중량 기준으로 칭량하였다: 173g의 시호, 115g의 작약, 133g의 태자삼, 52g의 지실, 68g의 금은화, 34g의 통초, 34g의 백목이, 21g의 황기, 68g의 당삼, 27g의 황금, 41g의 울금, 68g의 해금사, 141g의 연교, 및 34g의 포공영. 상기 원료들을 포함하는 중국 의약 조성물은 다음에 의해 제조된다: 연교, 태자삼 및 작약을 분쇄하고, 그것을 120 메쉬 체로 체질하여 미세 분말을 얻는 단계; 물과 함께 시호를 끓이고, 여과하여 여과액을 얻고, 상기 여과액을 농축시켜 60℃에서 측정 시 1.02 내지 1.03의 상대 밀도를 갖는 농고를 얻는 단계; 포공영, 통초, 당삼, 지실, 금은화, 황금, 및 울금을 증기 증류하여 휘발성 유를 추출하고, β-시클로덱스트린으로 상기 휘발성 유를 포접화하여 포접 화합물을 얻고, 상기 포접 화합물을 건조하고, 그것을 분말로 분쇄하고, 용기 내에 상기 분말을 두는 단계; 및 증기 증류 후에 얻어진 찌꺼기, 황기, 백목이, 및 해금사의 혼합물을 물과 함께 1시간씩, 3회 달여서 탕액을 얻고, 상기 탕액을 혼합하고, 여과하여 여과액을 얻고, 상기 여과액을 농축시켜 60℃에서 측정 시 1.25 내지 1.30의 상대 밀도를 갖는 농고를 얻고, 상기 시호 농고 및 연교, 태자삼 및 작약의 미세 분말을 첨가하여, 균일하게 혼합하고, 4% 전분 슬러리를 첨가하고, 균일하게 교반하고, 건조하고, 정립을 수행하고, 휘발성 유 포접 화합물 미세 분말 및 1% 스테아르산을 첨가하여, 캡슐제, 정제 또는 과립제로 만드는 단계.The raw materials were weighed on a weight basis as follows: 173 g of Sepharose, 115 g of peony, 133 g of Fenugreek, 52 g of flaxseed, 68 g of gold silver, 34 g of gum, 34 g of Baek, Of gold, 41g of corn, 68g of Haegeum, 141g of bridle, and 34g of porpoise. A Chinese medicinal composition comprising the above ingredients is prepared by: pulverizing alum, mandarin, peanut and peony and sieving it with a 120 mesh sieve to obtain a fine powder; Boiling the persimmon with water, filtering to obtain a filtrate, and concentrating the filtrate to obtain a hypercholesterol having a relative density of 1.02 to 1.03 as measured at 60 ° C; The volatile oil is extracted by steam distillation of the petroleum jelly, the bean sprout, the sugar bean ginseng, the persimmon ginseng, the golden ginseng, the golden ginseng, the golden ginseng, and the gilt wolf to obtain the inclusion compound by drying the volatile oil with? -Cyclodextrin, And placing the powder in a vessel; And a mixture of the residue, ylang, white lime and sea lime obtained after steam distillation was dwelling together with water for 3 hours to obtain a bath liquid, mixing the bath liquid and filtering to obtain a filtrate, and concentrating the filtrate A dense cake having a relative density of 1.25 to 1.30 as measured at 60 캜 is obtained, and the fine powder of the above-mentioned dense granules, Drying, sizing, and adding volatile oil inclusion compound micropowder and 1% stearic acid to make capsules, tablets or granules.
실시예 2Example 2
원료들을 다음과 같이 중량 기준으로 칭량하였다: 170g의 시호, 110g의 작약, 130g의 태자삼, 50g의 지실, 65g의 금은화, 30g의 통초, 30g의 백목이, 20g의 황기, 65g의 당삼, 25g의 황금, 40g의 울금, 65g의 해금사, 140g의 연교, 및 30g의 포공영. 상기 원료들을 포함하는 중국 의약 조성물은 다음에 의해 제조된다: 연교, 태자삼 및 작약을 분쇄하고, 그것을 120 메쉬 체로 체질하여 미세 분말을 얻는 단계; 물과 함께 시호를 끓이고, 여과하여 여과액을 얻고, 상기 여과액을 농축시켜 60℃에서 측정 시 1.02 내지 1.03의 상대 밀도를 갖는 농고를 얻는 단계; 포공영, 통초, 당삼, 지실, 금은화, 황금, 및 울금을 증기 증류하여 휘발성 유를 추출하고, β-시클로덱스트린으로 상기 휘발성 유를 포접화하여 포접 화합물을 얻고, 상기 포접 화합물을 건조하고, 그것을 분말로 분쇄하고, 용기 내에 상기 분말을 두는 단계; 및 증기 증류 후에 얻어진 찌꺼기, 황기, 백목이, 및 해금사의 혼합물을 물과 함께 1시간씩, 3회 달여서 탕액을 얻고, 상기 탕액을 혼합하고, 여과하여 여과액을 얻고, 상기 여과액을 농축시켜 60℃에서 측정 시 1.25 내지 1.30의 상대 밀도를 갖는 농고를 얻고, 상기 시호 농고 및 연교, 태자삼 및 작약의 미세 분말을 첨가하여, 균일하게 혼합하고, 4% 전분 슬러리를 첨가하고, 균일하게 교반하고, 건조하고, 정립을 수행하고, 휘발성 유 포접 화합물 미세 분말 및 1% 스테아르산을 첨가하여, 캡슐제, 정제 또는 과립제로 만드는 단계.The raw materials were weighed on a weight basis as follows: 170 g Sepharose, 110 g Peony root, 130 g Prunus mume, 50 g Seaweed, 65 g Gold silver, 30 g Prunus, 30 g Baekmu, 20 g Huanggi, 65 g sugar, 25 g Of gold, 40 grams of wool, 65 grams of Haegeum, 140 grams of brassiere, and 30 grams of porpoise. A Chinese medicinal composition comprising the above ingredients is prepared by: pulverizing alum, mandarin, peanut and peony and sieving it with a 120 mesh sieve to obtain a fine powder; Boiling the persimmon with water, filtering to obtain a filtrate, and concentrating the filtrate to obtain a hypercholesterol having a relative density of 1.02 to 1.03 as measured at 60 ° C; The volatile oil is extracted by steam distillation of the petroleum jelly, the bean sprout, the sugar bean ginseng, the persimmon ginseng, the golden ginseng, the golden ginseng, the golden ginseng, and the gilt wolf to obtain the inclusion compound by drying the volatile oil with? -Cyclodextrin, And placing the powder in a vessel; And a mixture of the residue, ylang, white lime and sea lime obtained after steam distillation was dwelling together with water for 3 hours to obtain a bath liquid, mixing the bath liquid and filtering to obtain a filtrate, and concentrating the filtrate A dense cake having a relative density of 1.25 to 1.30 as measured at 60 캜 is obtained, and the fine powder of the above-mentioned dense granules, Drying, sizing, and adding volatile oil inclusion compound micropowder and 1% stearic acid to make capsules, tablets or granules.
실시예 3Example 3
원료들을 다음과 같이 중량 기준으로 칭량하였다: 175g의 시호, 120g의 작약, 135g의 태자삼, 55g의 지실, 70g의 금은화, 40g의 통초, 40g의 백목이, 25g의 황기, 70g의 당삼, 30g의 황금, 45g의 울금, 70g의 해금사, 150g의 연교, 및 40g의 포공영. 상기 원료들을 포함하는 중국 의약 조성물은 다음에 의해 제조된다: 연교, 태자삼 및 작약을 분쇄하고, 그것을 120 메쉬 체로 체질하여 미세 분말을 얻는 단계; 물과 함께 시호를 끓이고, 여과하여 여과액을 얻고, 상기 여과액을 농축시켜 60℃에서 측정 시 1.02 내지 1.03의 상대 밀도를 갖는 농고를 얻는 단계; 포공영, 통초, 당삼, 지실, 금은화, 황금, 및 울금을 증기 증류하여 휘발성 유를 추출하고, β-시클로덱스트린으로 상기 휘발성 유를 포접화하여 포접 화합물을 얻고, 상기 포접 화합물을 건조하고, 그것을 분말로 분쇄하고, 용기 내에 상기 분말을 두는 단계; 및 증기 증류 후에 얻어진 찌꺼기, 황기, 백목이, 및 해금사의 혼합물을 물과 함께 1시간씩, 3회 달여서 탕액을 얻고, 상기 탕액을 혼합하고, 여과하여 여과액을 얻고, 상기 여과액을 농축시켜 60℃에서 측정 시 1.25 내지 1.30의 상대 밀도를 갖는 농고를 얻고, 상기 시호 농고 및 연교, 태자삼 및 작약의 미세 분말을 첨가하여, 균일하게 혼합하고, 4% 전분 슬러리를 첨가하고, 균일하게 교반하고, 건조하고, 정립을 수행하고, 휘발성 유 포접 화합물 미세 분말 및 1% 스테아르산을 첨가하여, 캡슐제, 정제 또는 과립제로 만드는 단계.The raw materials were weighed on a weight basis as follows: 175 g Sepharose, 120 g of peony root, 135 g of fenugreek, 55 g of flaxseed, 70 g of gold silver, 40 g of pine needle, 40 g of white pine, Of gold, 45 grams of ugly, 70 grams of Haegeum, 150 grams of bridle, and 40 grams of porpoise. A Chinese medicinal composition comprising the above ingredients is prepared by: pulverizing alum, mandarin, peanut and peony and sieving it with a 120 mesh sieve to obtain a fine powder; Boiling the persimmon with water, filtering to obtain a filtrate, and concentrating the filtrate to obtain a hypercholesterol having a relative density of 1.02 to 1.03 as measured at 60 ° C; The volatile oil is extracted by steam distillation of the petroleum jelly, the bean sprout, the sugar bean ginseng, the persimmon ginseng, the golden ginseng, the golden ginseng, the golden ginseng, and the gilt wolf to obtain the inclusion compound by drying the volatile oil with? -Cyclodextrin, And placing the powder in a vessel; And a mixture of the residue, ylang, white lime and sea lime obtained after steam distillation was dwelling together with water for 3 hours to obtain a bath liquid, mixing the bath liquid and filtering to obtain a filtrate, and concentrating the filtrate A dense cake having a relative density of 1.25 to 1.30 as measured at 60 캜 is obtained, and the fine powder of the above-mentioned dense granules, Drying, sizing, and adding volatile oil inclusion compound micropowder and 1% stearic acid to make capsules, tablets or granules.
담석을 앓고 있는 58명의 환자들은 상기 처방을 갖고 상기 방법에 의해 제조된 캡슐제, 정제 및 과립제로 임상적으로 투여되었고, 그 치료적 결과는 담석 환자 치료용 본 발명의 중국 의약 조성물의 총 유효율이 89.7%까지 인 것을 나타낸다. The 58 patients suffering from gallstones were clinically administered with capsules, tablets and granules prepared by the above method with the above prescription, and the therapeutic result was the total efficacy of the Chinese medicinal composition of the present invention for the treatment of gallstone patients 89.7%.
캡슐제로 투여된 환자들에 대한 임상적 관찰 결과를 표 1에 나타내었다:Clinical observations of patients administered with capsules are shown in Table 1:
(%)Number of patients
(%)
(%)Number of patients
(%)
(%)Number of patients
(%)
(%)Number of patients
(%)
Claims (2)
연교, 태자삼 및 작약을 분쇄하고, 그것을 120 메쉬 체로 체질(sieving) 하여 미세 분말을 얻는 단계;
물과 함께 시호를 끓이고, 여과하여 여과액을 얻고, 상기 여과액을 농축시켜 60℃에서 측정 시 1.02 내지 1.03의 상대 밀도를 갖는 농고 (stiff paste)를 얻는 단계;
포공영, 통초, 당삼, 지실, 금은화, 황금, 및 울금을 증기 (steam) 증류하여 휘발성 유 (volatile oil)를 추출하고, β-시클로덱스트린으로 상기 휘발성 유를 포접화 (clathration)하여 포접 화합물 (clathrate compound)을 얻고, 상기 포접 화합물을 건조하고, 그것을 분말로 분쇄하고, 용기 내에 상기 분말을 두는 단계; 및
증기 증류 후에 얻어진 찌꺼기 (dreg), 황기, 백목이, 및 해금사의 혼합물을 물과 함께 1시간씩, 3회 달여서 탕액을 얻고, 상기 탕액을 혼합하고, 여과하여 여과액을 얻고, 상기 여과액을 농축시켜 60℃에서 측정 시 1.25 내지 1.30의 상대 밀도를 갖는 농고를 얻고, 상기 시호 농고 및 연교, 태자삼 및 작약의 미세 분말을 첨가하여, 균일하게 혼합하고, 4% 전분 슬러리를 첨가하고, 균일하게 교반하고, 건조하고, 정립 (size stabilization: 整粒)을 수행하고, 휘발성 유 포접 화합물 미세 분말 및 1% 스테아르산을 첨가하여, 캡슐제, 정제 또는 과립제로 만드는 단계.A method for producing a Chinese medicine composition for treating gallstones according to claim 1, which comprises:
Pulverizing alum, alfalfa, fennel, and peony, and sieving it with a 120-mesh sieve to obtain a fine powder;
Boiling the seaweed together with water, filtering to obtain a filtrate, and concentrating the filtrate to obtain a stiff paste having a relative density of 1.02 to 1.03 as measured at 60 ° C;
Volatile oil is extracted by steam distillation from a mixture of glacial acetic acid, glacial acetic acid, ginseng, sugar bean ginseng, gilt earthen, golden ginseng and golden ginseng, clathration of the volatile oil with? -Cyclodextrin, compound, drying the inclusion compound, pulverizing it into a powder, and placing the powder in a container; And
A mixture of dreg, ylang, kaolin, and sea liquor obtained after steam distillation was dewatered three times with water for one hour to obtain a bath liquid. The bath liquid was mixed and filtered to obtain a filtrate. Concentrated to obtain a dense solution having a relative density of 1.25 to 1.30 as measured at 60 캜, adding the above-mentioned dense granules and the fine powder of dried granules, (Size stabilization), and adding volatile oil-containing compound fine powder and 1% stearic acid to make capsules, tablets or granules.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160067301A KR20170135416A (en) | 2016-05-31 | 2016-05-31 | A chinese medicine composition and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160067301A KR20170135416A (en) | 2016-05-31 | 2016-05-31 | A chinese medicine composition and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20170135416A true KR20170135416A (en) | 2017-12-08 |
Family
ID=60920215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160067301A KR20170135416A (en) | 2016-05-31 | 2016-05-31 | A chinese medicine composition and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20170135416A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108114105A (en) * | 2018-02-13 | 2018-06-05 | 西安医学院 | A kind of preparation method of Essential Oil of Acorus tatarinowii beta-cyclodextrin microballoon |
CN108159115A (en) * | 2018-02-13 | 2018-06-15 | 西安医学院 | A kind of preparation method of purple perilla volatile oil beta-cyclodextrin microballoon |
-
2016
- 2016-05-31 KR KR1020160067301A patent/KR20170135416A/en unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108114105A (en) * | 2018-02-13 | 2018-06-05 | 西安医学院 | A kind of preparation method of Essential Oil of Acorus tatarinowii beta-cyclodextrin microballoon |
CN108159115A (en) * | 2018-02-13 | 2018-06-15 | 西安医学院 | A kind of preparation method of purple perilla volatile oil beta-cyclodextrin microballoon |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103829238B (en) | Health food of a kind of reducing blood lipid and preparation method thereof | |
CN1840128A (en) | Medicine for treating cardiovascular disease | |
KR20170135416A (en) | A chinese medicine composition and preparation method thereof | |
CN100409870C (en) | Chinese traditional medicinal composition for treating psoriasis | |
CN1287830C (en) | Chinese traditional medicine compound preparation for treating gynecopathy and preparation method thereof | |
CN1052880C (en) | "Zhennaoning" capsule for treating angioneurotic headache | |
CN104225163B (en) | It is a kind of to treat pharmaceutical composition of alpastic anemia and its preparation method and application | |
CN108186794B (en) | Traditional Chinese medicine composition for treating lung cancer and preparation method and application thereof | |
CN105012686B (en) | A kind of pharmaceutical preparation and preparation method thereof for treating Shelled Turtle Trionyx Sinensis stress disease | |
CN102716423A (en) | Ruhesanjie capsule used for curing mammary hyperplasia diseases of women and preparation method thereof | |
CN112870267A (en) | New medicine for treating tumor and preparation method thereof | |
CN1250273C (en) | Venom capsule for treating brain cancer | |
CN104398975A (en) | Traditional Chinese medicinal preparation for treating fibroadenoma of breast and preparation method thereof | |
CN108542990A (en) | It is a kind of that there is the composition and preparation method thereof for adjusting livestock functions of intestines and stomach | |
CN103405603A (en) | Composite drug composition for treating anemia | |
CN105055857A (en) | Traditional Chinese medicine preparation for treating stress diseases of Chinese softshell turtles and preparation method of preparation | |
CN105288320A (en) | Traditional Chinese medicine preparation for treatment of oral ulcer and preparation method and applications thereof | |
CN108498575B (en) | Medicine for treating esophageal squamous carcinoma and preparation method thereof | |
KR20170136193A (en) | A Chinese medicine composition for treating gallstone | |
WO2023103126A1 (en) | Traditional chinese medicine composition having anti-cancer effect and preparation method therefor | |
CN105012395A (en) | Traditional Chinese medicine for treating swine influenza and application thereof | |
CN104906542A (en) | Traditional Chinese medicine composition for treating canine coronavirus infection and preparation method of traditional Chinese medicine composition | |
CN1679908A (en) | Chinese medicine for treating tumor and preparation thereof | |
CN112870294A (en) | Composition for resisting tumor | |
CN112022927A (en) | Traditional Chinese medicine formula for treating uremia |